Abstract
Clinical use of biologic agents, especially in the fields of hematology and oncology, is becoming increasingly common. Many agents, interferon-alpha, interferon-gamma, granulocyte and granulocyte-monocyte colony stimulating factors, erythropoietin, and interleukin-2 have already been approved for clinical use. Others are currently in clinical trials or will soon be available for administration to humans. This review summarizes the properties of interleukins 1 through 12, their derivation, activities, and approved or potential clinical uses.
| Original language | English |
|---|---|
| Pages (from-to) | 479-483 |
| Number of pages | 5 |
| Journal | The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society |
| Volume | 146 |
| Issue number | 11 |
| State | Published - Nov 1994 |
| Externally published | Yes |